Skip to main content

FAST FORWARD YOUR CANDIDATE SELECTION

Discovery

Expert scientific know-how, dedicated labs and rapid data delivery to enable informed decisions and improve your probability of success.
Contact us

The discovery stage plays a pivotal role in shaping the success of a drug development program, impacting efficiency, cost and long-term outcomes. However, challenges such as high attrition rates, complex biological targets and the right candidate selection can create significant hurdles. Implementing a robust de-risking strategy means that only the most promising compounds advance, while partnering with a trusted laboratory optimizes resource allocation, accelerates development and enhances the likelihood of success.

Discover your top drug candidate and fast-forward to IND

Collaborating with Labcorp provides a strategic edge by enabling smarter decision-making, minimizing risks and accelerating progress. Our comprehensive discovery solutions support rapid study initiation, timely data delivery and expert scientific guidance to drive informed decisions and improve success rates. Whether you're developing small molecules, biologics or advanced therapies, we help advance your top candidates from hit validation to selection and beyond.

  • Extend your team’s expertise with scientific collaboration and insights

  • Improve probability of success with trusted data and insightful data interpretation delivered rapidly

  • Accelerate your program at scale with our global capabilities delivered with urgency

Drug discovery capabilities

Understand the efficacy of your molecule and the metabolic and pharmacokinetic profile of your compound while anticipating and responding to discovery challenges earlier.

Pharmacology
DMPK
Safety Toxicology

Key therapeutic expertise

Our scientific leaders provide valuable insights based on decades of expertise and are dedicated to delivering high-quality data to meet your timelines.

Oncology
Respiratory Diseases
Infectious Disease

Modality specialties

Reduce the time and risk in all stages of development, create custom-made antibody reagents and access a comprehensive suite of discovery vaccine testing services.

Cell & Gene Therapy
Antibodies
Vaccines

Asset acquisition and exit

When your business goal is to exit, invest or partner, you can kick-start strategic conversations with the help of MarketPlace.

  • Expand your network by accessing our innovative platform that connects asset providers with asset seekers
  • Reach partnering goals faster by accelerating strategic conversations
  • Maximize the value of your partnering efforts; real connections are made every month
Discover MarketPlace
EBOOK

BLOG

Unlock the 3 keys to drug discovery success

Learn how to fast-track development of your discovery phase therapeutic to the next inflection point in a cost-efficient manner, derisk it and demonstrate the value needed to attract future investment.

Read the blog

NOW AVAILABLE

Patient-derived xenograft models

Improve your therapeutic efficacy predictions with our fully characterized patient-derived xenografts (PDX) representing multiple histotypes.

Unlock new possibilities with PDX

BROCHURE

Vaccine development testing

Leverage our scientific capabilities and experience for your next vaccine development project to save time and money.

Download the brochure

Frequently asked questions

Yes, we have BSL-2 space at our facilities in Ann Arbor, MI, and Denver, PA, and can work with a wide range of infectious agents. Learn more about our infectious disease and vaccine capabilities.

Yes, our discovery and safety teams work closely to efficiently run a study with efficacy, safety and PK, all under one roof. Explore our drug metabolism and pharmacokinetics (DMPK) solutions.

Yes, we have an inhalation delivery team at our Huntingdon site that can administer drug by the inhalation route for evaluation of efficacy, PK and safety.

Discovery DMPK screening can be done in a cost-effective manner. By leveraging technologies and resources, you can quickly and efficiently identify potential drug candidates with the desired pharmacokinetic properties. Learn about our in vitro screening capabilities.

Yes. Because our discovery teams are closely associated with safety teams, we can readily run combined studies that capture all these endpoints, allowing you to be more efficient investigating your discovery compounds.

Yes, we offer a wide range of non-GLP animal telemetry models to test your tool compound on blood pressure, ECG and cardiac function to help understand the cardiovascular risk. Explore cardiovascular safety assessments.

Explore nonclinical solutions for each stage of your drug development journey

Ready to Discover the One?